Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001595585-19-000019
Filing Date
2019-02-07
Accepted
2019-02-07 21:08:12
Documents
1
Period of Report
2019-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_154959167274616.html 4  
1 FORM 4 wf-form4_154959167274616.xml 4 12557
  Complete submission text file 0001595585-19-000019.txt   13956
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRICIDA, INC. 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address
COUFAL SANDRA I (Reporting) CIK: 0001744280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 19577096